Nowak P - Search Results

1

Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.

Sundén-Cullberg J, Chen P, Häbel H, Skorup P, Janols H, Rasmuson J, Niward K, Östholm Balkhed Å, Chatzidionysiou K, Asgeirsson H, Blennow O, Parke Å, Svensson AK, Muvva JR, Ljunggren HG; Karolinska KI/K COVID-19 Treatment Working Group; Horne AC, Ådén U, Henter JI, Sönnerborg A, Vesterbacka J, Nowak P, Lampa J. Sundén-Cullberg J, et al. Among authors: nowak p. PLoS One. 2023 Dec 29;18(12):e0295838. doi: 10.1371/journal.pone.0295838. eCollection 2023. PLoS One. 2023. PMID: 38157348 Free PMC article. Clinical Trial.

2

Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection.

Nowak P, Schvarcz R, Ericzon BG, Flamholc L, Sönnerborg A. Nowak P, et al. AIDS Res Hum Retroviruses. 2003 Jan 1;19(1):13-9. doi: 10.1089/08892220360473925. AIDS Res Hum Retroviruses. 2003. PMID: 12581512

3

Intracellular high mobility group B1 protein (HMGB1) represses HIV-1 LTR-directed transcription in a promoter- and cell-specific manner.

Naghavi MH, Nowak P, Andersson J, Sönnerborg A, Yang H, Tracey KJ, Vahlne A. Naghavi MH, et al. Among authors: nowak p. Virology. 2003 Sep 15;314(1):179-89. doi: 10.1016/s0042-6822(03)00453-7. Virology. 2003. PMID: 14517071 Free article.

4

Early induction of leukemia inhibitor factor (LIF) in acute HIV-1 infection.

Tjernlund A, Barqasho B, Nowak P, Kinloch S, Thorborn D, Perrin L, Sönnerborg A, Walther-Jallow L, Andersson J. Tjernlund A, et al. Among authors: nowak p. AIDS. 2006 Jan 2;20(1):11-9. doi: 10.1097/01.aids.0000198082.16960.94. AIDS. 2006. PMID: 16327314

5

HMGB1 activates replication of latent HIV-1 in a monocytic cell-line, but inhibits HIV-1 replication in primary macrophages.

Nowak P, Barqasho B, Treutiger CJ, Harris HE, Tracey KJ, Andersson J, Sönnerborg A. Nowak P, et al. Cytokine. 2006 Apr;34(1-2):17-23. doi: 10.1016/j.cyto.2006.03.010. Epub 2006 May 11. Cytokine. 2006. PMID: 16697213

6

Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection.

Nowak P, Barqasho B, Sönnerborg A. Nowak P, et al. AIDS. 2007 Apr 23;21(7):869-71. doi: 10.1097/QAD.0b013e3280b079b6. AIDS. 2007. PMID: 17415043

7

Implications of the release of high-mobility group box 1 protein from dying cells during human immunodeficiency virus type 1 infection in vitro.

Barqasho B, Nowak P, Abdurahman S, Walther-Jallow L, Sönnerborg A. Barqasho B, et al. Among authors: nowak p. J Gen Virol. 2010 Jul;91(Pt 7):1800-9. doi: 10.1099/vir.0.016915-0. Epub 2010 Mar 3. J Gen Virol. 2010. PMID: 20200191

8

Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.

Trøseid M, Nowak P, Nyström J, Lindkvist A, Abdurahman S, Sönnerborg A. Trøseid M, et al. Among authors: nowak p. AIDS. 2010 Jul 17;24(11):1733-7. doi: 10.1097/QAD.0b013e32833b254d. AIDS. 2010. PMID: 20502315

9

High mobility group box protein-1 in HIV-1 infection.

Trøseid M, Sönnerborg A, Nowak P. Trøseid M, et al. Among authors: nowak p. Curr HIV Res. 2011 Jan;9(1):6-10. doi: 10.2174/157016211794582632. Curr HIV Res. 2011. PMID: 21198433 Review.

10

Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection.

Nowak P, Abdurahman S, Lindkvist A, Troseid M, Sönnerborg A. Nowak P, et al. Int J Microbiol. 2012;2012:263836. doi: 10.1155/2012/263836. Epub 2012 Jun 6. Int J Microbiol. 2012. PMID: 22719767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters